Abstract
R51703, a substance with 5-hydroxytryptamine type 2 receptor antagonist properties, was studied to assess its potential as a sedative in cattle. Six cattle in the study group were given R51703 intramuscularly at a dose rate of 0.15 mg/kg. Sedation became obvious between 10 and 15 minutes postinjection in five of these animals and lasted for approximately 120 minutes. No significant changes (P less than or equal to 0.05) were observed in respiratory rate, arterial blood gas, acid-base values or systemic arterial blood pressure. Heart rate was significantly elevated at 40, 60, 90 and 120 minutes posttreatment, but dysrhythmias were not detected. Rumen motility, as judged by the contraction rate, was decreased but not to significant levels. All animals ate normally at the end of the study period. The results indicated that R51703 may have a role in the management of domestic cattle and that further work is indicated to assess its potential in this area.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Degryse A. D., Ooms L. A. Clinical evaluation of R 51163, a new sedative in cattle. J Vet Pharmacol Ther. 1986 Dec;9(4):376–384. doi: 10.1111/j.1365-2885.1986.tb00058.x. [DOI] [PubMed] [Google Scholar]
- Knight A. P. Xylazine. J Am Vet Med Assoc. 1980 Mar 1;176(5):454–455. [PubMed] [Google Scholar]
- Ruckebusch Y., Ooms L. A., Degryse A. D., Allal C. Alleviation of excessive gas accumulation in the ruminant stomach by ritanserin. Am J Vet Res. 1985 Feb;46(2):434–437. [PubMed] [Google Scholar]
- Van Nueten J. M., Janssens W. J., Vanhoutte P. M. Serotonin and vascular reactivity. Pharmacol Res Commun. 1985 Jul;17(7):585–608. doi: 10.1016/0031-6989(85)90067-0. [DOI] [PubMed] [Google Scholar]